In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

PowderJect acquires Swedish company SBL Vaccin

Executive Summary

PowderJect Pharmaceuticals (needlefree injection systems) acquired Active Biotech's wholly owned subsidiary SBL Vaccin AB (travel vaccines) for $50.2mm (UK35.4mm) up front--$12.6mm in cash and the remaining through the issuance of ordinary shares--to enhance its vaccine pipeline and increase its sales, marketing, and distribution efforts.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • Vaccines
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Earnout
    • Intra-Biotech Deal
    • Payment Includes Cash

Related Companies